Atria Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.02M | Buy |
11,469
+1,442
| +14% | +$757K | 0.07% | 323 |
|
|
2025
Q1 | $6.36M | Buy |
10,027
+3,390
| +51% | +$2.15M | 0.08% | 287 |
|
|
2024
Q4 | $4.73M | Sell |
6,637
-1,685
| -20% | -$1.2M | 0.06% | 370 |
|
|
2024
Q3 | $8.75M | Sell |
8,322
-281
| -3% | -$295K | 0.11% | 212 |
|
|
2024
Q2 | $9.04M | Sell |
8,603
-54
| -0.6% | -$56.8K | 0.12% | 190 |
|
|
2024
Q1 | $8.32M | Buy |
8,657
+941
| +12% | +$904K | 0.11% | 206 |
|
|
2023
Q4 | $6.76M | Buy |
7,716
+566
| +8% | +$496K | 0.1% | 227 |
|
|
2023
Q3 | $5.87M | Sell |
7,150
-420
| -6% | -$345K | 0.1% | 242 |
|
|
2023
Q2 | $5.43M | Sell |
7,570
-383
| -5% | -$275K | 0.1% | 241 |
|
|
2023
Q1 | $6.52M | Buy |
7,953
+295
| +4% | +$242K | 0.12% | 201 |
|
|
2022
Q4 | $5.52M | Sell |
7,658
-585
| -7% | -$421K | 0.11% | 225 |
|
|
2022
Q3 | $5.68M | Buy |
8,243
+324
| +4% | +$223K | 0.13% | 203 |
|
|
2022
Q2 | $4.68M | Sell |
7,919
-1,138
| -13% | -$673K | 0.1% | 244 |
|
|
2022
Q1 | $6.33M | Sell |
9,057
-992
| -10% | -$693K | 0.11% | 218 |
|
|
2021
Q4 | $6.35M | Buy |
10,049
+1,961
| +24% | +$1.24M | 0.11% | 221 |
|
|
2021
Q3 | $4.9M | Sell |
8,088
-349
| -4% | -$211K | 0.09% | 254 |
|
|
2021
Q2 | $4.71M | Buy |
8,437
+286
| +4% | +$160K | 0.09% | 252 |
|
|
2021
Q1 | $3.86M | Sell |
8,151
-2,053
| -20% | -$971K | 0.09% | 272 |
|
|
2020
Q4 | $4.93M | Sell |
10,204
-134
| -1% | -$64.7K | 0.12% | 199 |
|
|
2020
Q3 | $5.79M | Sell |
10,338
-7,088
| -41% | -$3.97M | 0.18% | 134 |
|
|
2020
Q2 | $10.9M | Buy |
17,426
+7,075
| +68% | +$4.41M | 0.37% | 60 |
|
|
2020
Q1 | $5.05M | Buy |
10,351
+2,616
| +34% | +$1.28M | 0.39% | 64 |
|
|
2019
Q4 | $2.9M | Buy |
7,735
+6,800
| +727% | +$2.55M | 0.08% | 221 |
|
|
2019
Q3 | $259K | Buy |
935
+107
| +13% | +$29.6K | 0.01% | 759 |
|
|
2019
Q2 | $248K | Buy |
828
+63
| +8% | +$18.9K | 0.01% | 812 |
|
|
2019
Q1 | $314K | Buy |
765
+42
| +6% | +$17.2K | 0.01% | 685 |
|
|
2018
Q4 | $270K | Sell |
723
-403
| -36% | -$150K | 0.01% | 690 |
|
|
2018
Q3 | $455K | Sell |
1,126
-371
| -25% | -$150K | 0.02% | 620 |
|
|
2018
Q2 | $516K | Buy |
1,497
+147
| +11% | +$50.7K | 0.02% | 564 |
|
|
2018
Q1 | $465K | Sell |
1,350
-580
| -30% | -$200K | 0.02% | 535 |
|
|
2017
Q4 | $726K | Buy |
1,930
+647
| +50% | +$243K | 0.04% | 403 |
|
|
2017
Q3 | $574K | Buy |
1,283
+115
| +10% | +$51.5K | 0.03% | 429 |
|
|
2017
Q2 | $574K | Buy |
1,168
+86
| +8% | +$42.3K | 0.04% | 400 |
|
|
2017
Q1 | $419K | Buy |
1,082
+120
| +12% | +$46.5K | 0.03% | 430 |
|
|
2016
Q4 | $353K | Buy |
962
+290
| +43% | +$106K | 0.03% | 421 |
|
|
2016
Q3 | $270K | Buy |
+672
| New | +$270K | 0.02% | 431 |
|